Media, PA, United States of America

William F DeGrado

This inventor holds 22 USPTO granted patents and 8 published patent applications and 1 EPO patent, primarily in Amphiphilic Polymers. Top assignees: University of Pennsylvania, The Dupont Merck Pharmaceutical Company, Cellceutix Corporation. Active years: 1996-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William F DeGrado. Retrieved from https://idiyas.com/inventor/william-f-degrado

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22 

% Patents Active = 68.2

 

Average Co-Inventor Count = 3.5

ph-index = 9

Forward Citations = 177(Granted Patents)


Location History:

  • Philadelphia, PA (US) (1997)
  • Moylan, PA (US) (1996 - 2016)
  • Media, PA (US) (2004 - 2016)

Company Filing History:


Years Active: 1996-2016

Loading Chart...
Loading Chart...
Areas of Expertise:
Influenza A Virus
Proton Channel Inhibition
Amphiphilic Polymers
Antibacterial Peptides
Host Defense Mimetics
Integrin Inhibitors
Metalloprotease Inhibitors
Spiro-Piperidine Compounds
Polypeptides
Synthetic Mimetics
Macrocyclic Compounds
22 patents (USPTO):Explore Patents

Title: The Innovative Journey of William F. DeGrado

Introduction

William F. DeGrado, an accomplished inventor based in Media, PA, has made significant contributions to the field of biomedical research. With a total of 18 patents to his name, his work primarily focuses on developing innovative compounds for treating infectious diseases, particularly those caused by the influenza A virus.

Latest Patents

DeGrado's recent patents showcase his pioneering efforts in antiviral research. One of his notable inventions is centered around "Influenza A virus inhibition." This patent describes compounds that modulate the activity of the influenza A virus by interacting with the M2 transmembrane protein. Furthermore, the patent outlines meticulous methods for treating diseases or infections associated with influenza A, through the administration of these innovative compounds.

Another significant patent by DeGrado is the "Inhibition of influenza M2 proton channel." Similar to his previous work, it involves compounds that interact with the M2 protein, marking a continued commitment to finding effective treatments for influenza A-related conditions.

Career Highlights

William F. DeGrado has been affiliated with prestigious institutions throughout his career, including the University of Pennsylvania, where he honed his research skills and contributed to various groundbreaking studies. Additionally, he has worked with Polymedix, Inc., further expanding his influence in the pharmaceutical sector as he drives forward innovations in drug development.

Collaborations

Throughout his career, DeGrado has collaborated with notable researchers, enhancing his work's scope and impact. Two of his colleagues, Dahui Liu and Michael L. Klein, have been pivotal in various research initiatives that have contributed to the development and refinement of his inventions.

Conclusion

William F. DeGrado's journey as an inventor exemplifies the spirit of innovation in the biomedical field. His 18 patents, particularly in the realm of influenza A virus inhibition, reflect a dedication to enhancing public health through scientific discovery. As he continues to collaborate and innovate, the potential for future breakthroughs under his guidance remains promising.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…